| Title: | Impact of germline VHL variants on oncologic and metabolic phenotypes in adult Biobank participants |
| Lead Institution: | The Chaim Sheba Medical Center |
| Principal investigator: | Dr Amit Tirosh |
Application 70580
WARNING: the interactive features of this website use CSS3, which your browser does not support. To use the full features of this website, please update your browser.
About
Aims. Von Hippel-Lindau disease (VHL), increase risk for several tumors of the central nervous syndrome, kidneys, pancreas, adrenal and others. We wish to study whether specific genetic variation that are currently considered innocent, lead to the syndrome and whether they are associated with disease severity and outcome. We also want to investigate their association with metabolic syndrome, as was previously suggested Rationale. Several studies suggested genetic relevance for apparently innocent ("silent") genetic alterations in VHL gene, and association of VHL gene alteration with clinically significant manifestations. Duration. 36 months Public health impact. First, our study may enable stratification of morbidity and mortality according to specific VHL variants and thus allow planning patient-specific follow-up and intervention program. Identifying clinical significance by apparently innocent genetic variants will expand the patient population that is diagnosed with VHL and may pronouncedly impact their clinical surveillance and management. Second, we will assess whether changes in the VHL gene are associated with metabolic diseases, such as diabetes, obesity, and the related consequences of cardiovascular disease. Such association was suggested, but has never been examined in a large cohort, and can be readily extrapolated from the UK biobank dataset. Finally, we will suggest patient-specific surveillance program with the aim of earlier identification of VHL related morbidity thus possibly improving patient outcome.1 Publication
| Pub ID | Title | Author(s) | Year | Journal |
|---|---|---|---|---|
| 15071 | Pseudohypoxia caused by germline genetic alterations in the VHL gene is associated with increased diabetes and cardiovascular risk: a UK biobank study | Reut Halperin (+3) | 2025 | Cardiovascular Diabetology |
Enabling scientific discoveries that improve human health